| Citation: |
LIN Shuantong, SU Xiaojun, CAO Dequan. Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 192-197. DOI: 10.12290/xhyxzz.2024-0200
|
Hypertrophic cardiomyopathy, a genetic hereditary disease, is highly regarded in clinical practice due to its unique pathophysiological changes, course characteristics, and hemodynamic features. With the continuous advance of treatment methods such as medications and surgeries, the prevention, treatment and prognosis of hypertrophic cardiomyopathy has gradually improved. However, inappropriate use of positive inotropic drugs may lead to serious consequences that are difficult to reverse. Therefore, how to smoothly navigate through the perioperative period and ensure clinical safety poses a great challenge for anesthesiologists. This paper discusses the perioperative management of patients with hypertrophic cardiomyopathy, with the hope of enhancing anesthesiologists' management capabilities for this type of disease.
| [1] |
Maron B J, Desai M Y, Nishimura R A, et al. Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2022, 79(4): 372-389. DOI: 10.1016/j.jacc.2021.12.002
|
| [2] |
Rowin E J, Link M S, Maron M S, et al. Evolving contemporary management of atrial fibrillation in hypertrophic cardiomyopathy[J]. Circulation, 2023, 148(22): 1797-1811. DOI: 10.1161/CIRCULATIONAHA.123.065037
|
| [3] |
Glavaški M, Velicki L, Vučinić N. Hypertrophic cardiomyopathy: genetic foundations, outcomes, interconnections, and their modifiers[J]. Medicina (Kaunas), 2023, 59(8): 1424. DOI: 10.3390/medicina59081424
|
| [4] |
Cao S, Yang L J, Liu L Y, et al. Ultrasound study of right ventricular myocardial perfusion and functional changes in hypertrophic cardiomyopathy[J]. BMC Cardiovasc Disord, 2024, 24(1): 63. DOI: 10.1186/s12872-024-03705-5
|
| [5] |
国家心血管病专家委员会心力衰竭专业委员会, 中国医师协会心力衰竭专业委员会, 中华医学会心血管分会心力衰竭学组, 等. 中国肥厚型心肌病指南2022[J]. 中华心力衰竭和心肌病杂志, 2022, 6(2): 80-105. DOI: 10.3760/cma.j.cn1101460-20220805-00070
National Cardiovascular Disease Expert Committee Heart Failure Professional Committee, Chinese Medical Association Heart Failure Professional Committee, Heart Failure Group of the Cardiovascular Branch of the Chinese Medical Association, et al. 2022 Chinese guideline on hypertrophic cardiomyopathy[J]. Chin J Heart Fail Cardiomyopathy, 2022, 6(2): 80-105. DOI: 10.3760/cma.j.cn1101460-20220805-00070
|
| [6] |
Geske J B, Ommen S R, Gersh B J. Hypertrophic cardiomyopathy: clinical update[J]. JACC Heart Fail, 2018, 6(5): 364-375. DOI: 10.1016/j.jchf.2018.02.010
|
| [7] |
Ommen S R, Semsarian C. Hypertrophic cardiomyopathy: a practical approach to guideline directed management[J]. Lancet, 2021, 398(10316): 2102-2108. DOI: 10.1016/S0140-6736(21)01205-8
|
| [8] |
Rowin E J, Maron B J, Carrick R T, et al. Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction[J]. J Am Coll Cardiol, 2020, 75(24): 3033-3043. DOI: 10.1016/j.jacc.2020.04.045
|
| [9] |
Tuohy C V, Kaul S, Song H K, et al. Hypertrophic cardiomyopathy: the future of treatment[J]. Eur J Heart Fail, 2020, 22(2): 228-240. DOI: 10.1002/ejhf.1715
|
| [10] |
Guigui S A, Torres C, Escolar E, et al. Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review[J]. J Thorac Dis, 2022, 14(6): 2309-2325. DOI: 10.21037/jtd-22-182
|
| [11] |
Gartzonikas I K, Naka K K, Anastasakis A. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy[J]. Hellenic J Cardiol, 2023, 70: 65-74. DOI: 10.1016/j.hjc.2022.11.002
|
| [12] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 心脏再同步治疗慢性心力衰竭的中国专家共识(2021年修订版)[J]. 中华心律失常学杂志, 2021, 25(6): 465-478. DOI: 10.3760/cma.j.cn113859-20210901-00177
Chinese Society of Pacing and Electrophysiology, Chinese Society of Arrhythmias. Chinese expert consensus on the cardiac resynchronization therapy in patients with chronic heart failure (update 2021)[J]. Chin J Cardiac Arrhyth, 2021, 25(6): 465-478. DOI: 10.3760/cma.j.cn113859-20210901-00177
|
| [13] |
中华医学会心血管病学分会, 中国医师协会心血管内科医师分会, 中国医师协会心力衰竭专业委员会, 等. 中国心力衰竭诊断和治疗指南2024[J]. 中华心血管病杂志, 2024, 52(3): 235-275.
Chinese Society of Cardiology, Chinese Medical Association, Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, et al. Chinese guidelines for the diagnosis and treatment of heart failure 2024[J]. Chin J Cardiol, 2024, 52(3): 235-275.
|
| [14] |
中国研究型医院学会《冠状动脉心肌桥诊断与治疗专家共识》专家组. 冠状动脉心肌桥诊断与治疗的专家共识[J]. 中国研究型医院, 2022, 9(5): 1-8.
Experts Group for the Diagnosis and Treatment of Coronary Artery Myocardial Bridging of Chinese Research Hospital Association. Expert consensus on the diagnosis and treatment of coronary artery myocardial bridging[J]. Chin Res Hosp, 2022, 9(5): 1-8.
|
| [15] |
吴小朋, 李一丹, 吕秀章. 右心室肥厚型心肌病研究进展[J]. 中华心血管病杂志, 2018, 46(12): 1001-1004. DOI: 10.3760/cma.j.issn.0253-3758.2018.12.015
Wu X P, Li Y D, Lyu X Z. Research progress on the right ventricular hypertrophic cardiomyopathy[J]. Chin J Cardiol, 2018, 46(12): 1001-1004. DOI: 10.3760/cma.j.issn.0253-3758.2018.12.015
|
| [16] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 心脏再同步治疗慢性心力衰竭的中国专家共识(2021年修订版)[J]. 中华心律失常学杂志, 2021, 25(6): 465-478. DOI: 10.3760/cma.j.cn113859-20210901-00177
Chinese Society of Pacing and Electrophysiology, Chinese Society of Arrhythmias. Chinese expert consensus on the cardiac resynchronization therapy in patients with chronic heart failure (update 2021)[J]. Chin J Cardiac Arrhyth, 2021, 25(6): 465-478. DOI: 10.3760/cma.j.cn113859-20210901-00177
|
| [17] |
中华医学会心血管病学分会, 中国医师协会心血管内科医师分会, 中国医师协会心力衰竭专业委员会, 等. 中国心力衰竭诊断和治疗指南2024[J]. 中华心血管病杂志, 2024, 52(3): 235-275.
Chinese Society of Cardiology, Chinese Medical Association, Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, et al. Chinese guidelines for the diagnosis and treatment of heart failure 2024[J]. Chin J Cardiol, 2024, 52(3): 235-275.
|
| [18] |
郑舒文, 王喆, 翟振国, 等. 左心衰竭相关肺动脉高压的研究进展[J]. 中华内科杂志, 2024, 63(1): 113-120. DOI: 10.3760/cma.j.cn112138-20231024-00249
Zheng S W, Wang Z, Zhai Z G, et al. Progresses in pulmonary hypertension associated with left-sided heart failure[J]. Chin J Intern Med, 2024, 63(1): 113-120. DOI: 10.3760/cma.j.cn112138-20231024-00249
|
| [19] |
Ommen S R, Mital S, Burke M A, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J]. Circulation, 2020, 142(25): e533-e557.
|
| [20] |
中华医学会超声医学分会超声心动图学组, 中国超声医学工程学会超声心动图专业委员会. 肥厚型心肌病超声心动图检查规范专家共识[J]. 中华医学超声杂志(电子版), 2020, 17(5): 394-408.
Echocardiography Group of Chinese Medical Association Ultrasound Medical Branch, Specialty Committee of Echocardiography, Chinese Association of Ultrasound in Medicine and Engineering. Expert consensus on echocardiography in diagnosis of hypertrophic cardiomyopathy[J]. Chin J Med Ultrasound (Electron Ed), 2020, 17(5): 394-408.
|
| [21] |
Palmisano A, Vignale D, Peretto G, et al. Hybrid FDG-PET/MR or FDG-PET/CT to detect disease activity in patients with persisting arrhythmias after myocarditis[J]. JACC Cardiovasc Imaging, 2021, 14(1): 288-292. DOI: 10.1016/j.jcmg.2020.03.009
|
| [22] |
国家心血管病中心心肌病专科联盟, 中国医疗保健国际交流促进会心血管病精准医学分会"中国成人肥厚型心肌病诊断与治疗指南2023"专家组. 中国成人肥厚型心肌病诊断与治疗指南2023[J]. 中国循环杂志, 2023, 38(1): 1-33.
National Cardiovascular Disease Center Cardiomyopathy Specialty Alliance, Expert group of the Cardiovascular Precision Medicine Branch of the China Association for the Promotion of International Exchange in Healthcare, entitled "Diagnosis and Treatment Guidelines for Adult Hypertrophic Cardiomyopathy in China 2023". 2023 Guideline for diagnosis and treatment of patients with hypertrophic cardiomyopathy[J]. Chin Circul J, 2023, 38(1): 1-33.
|
| [23] |
Han C, Zhou M Y, Hu R, et al. Trans-septal myocardial biopsy in hypertrophic cardiomyopathy using the Liwen procedure: an introduction of a novel technique[J]. J Interv Cardiol, 2021, 2021: 1905184.
|
| [24] |
Li J, Zhang J, Shi Y, et al. Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation[J]. Heart, 2023, 109(4): 289-296. DOI: 10.1136/heartjnl-2022-321597
|
| [25] |
Zhou M Y, Ta S J, Hahn R T, et al. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy[J]. JAMA Cardiol, 2022, 7(5): 529-538. DOI: 10.1001/jamacardio.2022.0259
|
| [26] |
Xu Y, Yu T Y, Pu Z X. Percutaneous intramyocardial septal radiofrequency ablation relieving residual left ventricular outflow tract obstruction following alcohol septal ablation[J]. CASE (Phila), 2022, 6(7): 340-343.
|
| [27] |
Hu B L, Zhang M, Wu Z, et al. Comparison of remimazolam tosilate and etomidate on hemodynamics in cardiac surgery: a randomised controlled trial[J]. Drug Des Devel Ther, 2023, 17: 381-388. DOI: 10.2147/DDDT.S401969
|
| [28] |
Maron B J, Desai M Y, Nishimura R A, et al. Management of hypertrophic cardiomyopathy: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2022, 79(4): 390-414. DOI: 10.1016/j.jacc.2021.11.021
|
| [29] |
Shirani J, Aurshiya R, Elshaikh A, et al. Low risk of hypertrophic cardiomyopathy with contemporary manage-ment strategies implemented in non-referral regional community-based practices[J]. Am J Cardiol, 2021, 142: 130-135. DOI: 10.1016/j.amjcard.2020.11.035
|
| [30] |
Zhang R, Zhao F, Wang J, et al. Case report: integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm[J]. Front Cardiovasc Med, 2023, 10: 1278457. DOI: 10.3389/fcvm.2023.1278457
|
| [31] |
Hodges K, Rivas C G, Aguilera J, et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center[J]. J Thorac Cardiovasc Surg, 2019, 157(6): 2289-2299. DOI: 10.1016/j.jtcvs.2018.11.148
|
| [32] |
Boll G, Rowin E J, Maron B J, et al. Efficacy of combined Cox-Maze IV and ventricular septal myectomy for treatment of atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy[J]. Am J Cardiol, 2020, 125(1): 120-126. DOI: 10.1016/j.amjcard.2019.09.029
|
| [33] |
Nguyen A, Schaff H V, Nishimura R A, et al. Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure[J]. J Thorac Cardiovasc Surg, 2020, 159(1): 145-152. DOI: 10.1016/j.jtcvs.2019.03.088
|
| [34] |
Mitra S, Ramanathan K, MacLaren G. Post-operative management of hypertrophic obstructive cardiomyopathy[J]. Asian Cardiovasc Thorac Ann, 2022, 30(1): 57-63. DOI: 10.1177/02184923211069189
|
| [35] |
Zhu C S, Wang S Y, Ma Y, et al. Childhood hypertrophic obstructive cardiomyopathy and its relevant surgical outcome[J]. Ann Thorac Surg, 2020, 110(1): 207-213. DOI: 10.1016/j.athoracsur.2019.10.016
|
| [36] |
Mitra M, Basu M, Shailendra K, et al. Use of peripheral nerve blocks in perioperative management of cases with hypertrophic cardiomyopathy undergoing lower limb orthopedic surgeries[J]. Anesth Essays Res, 2020, 14(2): 277-282. DOI: 10.4103/aer.AER_48_20
|
| [37] |
Platonov P G, Castrini A I, Svensson A, et al. Pregnancies, ventricular arrhythmias, and substrate progression in women with arrhythmogenic right ventricular cardiomyopathy in the Nordic ARVC Registry[J]. Europace, 2020, 22(12): 1873-1879. DOI: 10.1093/europace/euaa136
|
| [38] |
Wu L M, Liang E P, Fan S Y, et al. Effect of pregnancy in arrhythmogenic right ventricular cardiomyopathy[J]. Am J Cardiol, 2020, 125(4): 613-617. DOI: 10.1016/j.amjcard.2019.11.008
|
| [39] |
Castrini A I, Skjølsvik E, Estensen M E, et al. Pregnancy and progression of cardiomyopathy in women with LMNA genotype-positive[J]. J Am Heart Assoc, 2022, 11(8): e024960. DOI: 10.1161/JAHA.121.024960
|
| [40] |
Davis M B, Arany Z, McNamara D M, et al. Peripartum cardiomyopathy: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 75(2): 207-221. DOI: 10.1016/j.jacc.2019.11.014
|
| [1] | ZHAO Bangbo, WANG Weibin, ZHAO Yupei. Current Status and Future of Robotic Pancreatic Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 729-733. DOI: 10.12290/xhyxzz.2024-0365 |
| [2] | YAN Jia, SHEN Le, JIANG Hong, HUANG Yuguang. A Survey of the Current Status of Anesthesiology for Plastic and Cosmetic Surgery in China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 440-448. DOI: 10.12290/xhyxzz.2022-0107 |
| [3] | LI Mohan, SUN Fengrun, WANG Tao, HE Yumiao, MA Chao, HUANG Yuguang. Transdermal Technology of Local Anesthetics in Plastic and Cosmetic Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 358-362. DOI: 10.12290/xhyxzz.2022-0044 |
| [4] | LI Yi, LIU Zijia, LABA Ciren, SHEN Le. New Advances in Anesthesia Management of Enhanced Recovery After Surgery in Craniotomy[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 774-779. DOI: 10.12290/xhyxzz.20200265 |
| [5] | Xiang YAN, Min ZENG, Jia DONG, Yu-ming PENG, Ru-quan HAN. The Application of Enhanced Recovery after Surgery in Perioperative Anesthesia Management of Neurosurgery[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 615-620. DOI: 10.3969/j.issn.1674-9081.2019.06.012 |
| [6] | Working Group of "Expert Consensus on Anesthesia Management of Enhanced Recovery after Ambulatory Surgery". Expert Consensus on Anesthesia Management of Enhanced Recovery after Adult Ambulatory Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 562-569. DOI: 10.3969/j.issn.1674-9081.2019.06.003 |
| [7] | Guang-yan XU, Li XU, Zi-jia LIU, Yu-guang HUANG. Predictive Value of Preoperative Assessment Tools for Perioperative Major Adverse Cardiac Event in Patients Undergoing Noncardiac Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 518-523. DOI: 10.3969/j.issn.1674-9081.2019.05.016 |
| [8] | Tian-long WANG, Yu-guang HUANG. Campaigning for the Transformation from Anesthesiology to Perioperative Medicine: Interpretation on the Anesthesia Part of Consensus on ERAS and Guidelines for the Pathway Management in China (2018)[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 481-484. DOI: 10.3969/j.issn.1674-9081.2018.06.001 |
| [9] | Xiao YANG, Bin WU, Yi XIAO, Guo-le LIN, Bei-zhan NIU, Hui-zhong QIU. Surgery for Rectal Carcinoids of 1-2 cm in Diameter in 31 Patients[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 429-431. DOI: 10.3969/j.issn.1674-9081.2014.04.015 |
| [10] | Xia RUAN, Wei LIU, Gang TAN, Xu-lei CUI, Yu-guang HUANG. Effect of Total Intravenous Anesthesia on Wake-up Test in Adolescent Patients Undergoing Scoliosis Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(2): 147-150. DOI: 10.3969/j.issn.1674-9081.2011.02.012 |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: